Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin mesylate in advanced soft tissue sarcoma
NCT01458249Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in soft tissue sarcoma (STS), sponsored by Eisai Co., Ltd.. Started Nov 2011; status: completed.
02
Drugs
eribulin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01458249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458249.